Bookmark
Forward
SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy.
Magdalena M Gerlach, Anna Stelling-Germani, Cheuk Ting Wu, Sebastian Newrzela, Claudia Döring, Visar Vela, Anne Müller, Sylvia Hartmann, Alexandar Tzankov
Haematologica 2021 Feb 01Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Magdalena M Gerlach, Anna Stelling-Germani, Cheuk Ting Wu, Sebastian Newrzela, Claudia Döring, Visar Vela, Anne Müller, Sylvia Hartmann, Alexandar Tzankov. SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy. Haematologica. 2021 Feb 01;106(2):619-621
Mesh Tags
Substances
PMID: 32299904
View Full Text
